Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Aviragen Therapeutics (AVIR) Tops Q2 EPS by 13c

August 8, 2023 4:23 PM EDT

Aviragen Therapeutics (NASDAQ: AVIR) reported Q2 EPS of ($0.34), $0.13 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

... More